Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial - Walters, A S; Ondo, W G; Kushida, C A; XP045 Study Group (Clin Neuropharmacol, 2009)